{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:42:15Z","timestamp":1794980535772,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010805","name":"Research Council of Southeast Sweden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cgh.2025.06.037","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:44:59Z","timestamp":1753202699000},"page":"503-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0294-4032","authenticated-orcid":false,"given":"Maie","family":"Abdalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eberhardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Landerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Myrelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2025.06.037_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","article-title":"Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study","volume":"5","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.06.037_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2025.06.037_bib3","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn\u2019s disease: a meta-analysis of population-based cohort studies","volume":"100","author":"Jess","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.037_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.06.037_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.037_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.18.s2.2.x","article-title":"Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease","volume":"18","author":"Munkholm","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.06.037_bib7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.06.037_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02587230","article-title":"Clinical experiences at St. Mark's Hospital with multiple synchronous cancers of the colon and rectum","volume":"18","author":"Heald","year":"1975","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2025.06.037_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcol.2013.02.004","article-title":"Incidence and epidemiological features of synchronous and metachronous colorectal cancer","volume":"33","author":"Brambilla","year":"2013","journal-title":"J Coloproctol (Rio de Janeiro)"},{"key":"10.1016\/j.cgh.2025.06.037_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjsurg.2010.05.012","article-title":"Clinicopathological significance of synchronous carcinoma in colorectal cancer","volume":"202","author":"Lam","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.cgh.2025.06.037_bib11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/bjs.6382","article-title":"Epidemiology and prognosis of synchronous colorectal cancers","volume":"95","author":"Latournerie","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2025.06.037_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/DCR.0b013e318242620f","article-title":"Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study","volume":"55","author":"Gearhart","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2025.06.037_bib13","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ibd.20886","article-title":"More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Claessen","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.06.037_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2025.06.037_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/apt.14393","article-title":"Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC\u2212IBD patients","volume":"47","author":"Nordenvall","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2025.06.037_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.06.037_bib17","article-title":"Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014","volume":"358","author":"Ol\u00e9n","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2025.06.037_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1053\/j.gastro.2018.10.028","article-title":"Increased mortality of patients with childhood-onset inflammatory bowel diseases, compared with the general population","volume":"156","author":"Ol\u00e9n","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.037_bib19","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.14309\/ajg.0000000000001941","article-title":"Inflammatory bowel disease-associated colorectal cancer epidemiology and outcomes: an English population-based study","volume":"117","author":"Birch","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.037_bib20","series-title":"Textbook of Pediatric Gastroenterology, Hepatology and Nutrition: A Comprehensive Guide to Practice","first-page":"393","article-title":"Inflammatory bowel disease unclassified (IBD-U)\/indeterminate colitis","author":"Kirschner","year":"2022"},{"key":"10.1016\/j.cgh.2025.06.037_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","article-title":"Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG)","volume":"52","author":"Jakobsson","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.037_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00365521.2018.1564361","article-title":"Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients","volume":"54","author":"Everhov","year":"2019","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.037_bib23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10620-015-3940-1","article-title":"Survival of colorectal cancer in patients with or without inflammatory bowel disease: a meta-analysis","volume":"61","author":"Ou","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2025.06.037_bib24","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ecco-jcc\/jjac090","article-title":"Increased risk of non-conventional and invisible dysplasias in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"16","author":"Zhang","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2025.06.037_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","article-title":"Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon","volume":"16","author":"Cleveland","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.06.037_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ibd\/izad137","article-title":"A gradient of intestinal inflammation in primary sclerosing cholangitis","volume":"30","author":"Wittek","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.06.037_bib27","doi-asserted-by":"crossref","first-page":"i104","DOI":"10.1136\/ard.2010.140145","article-title":"Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage","volume":"70","author":"Grivennikov","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2025.06.037_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13053-019-0118-4","article-title":"Colorectal carcinoma in the course of inflammatory bowel diseases","volume":"17","author":"Hnatyszyn","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.cgh.2025.06.037_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.772101","article-title":"Inflammatory bowel disease and risk of colorectal cancer: an overview from pathophysiology to pharmacological prevention","volume":"12","author":"Lucaf\u00f2","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cgh.2025.06.037_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221098849","article-title":"Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients","volume":"15","author":"Reijntjes","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.037_bib31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ibd\/izac127","article-title":"The role of appendicectomy in ulcerative colitis: systematic review and meta-analysis","volume":"29","author":"Welsh","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2025.06.037_bib32","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","article-title":"Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis","volume":"160","author":"Kummen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.037_bib33","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2021.05.028","article-title":"Feeding the gut\u2013liver axis in PSC: what makes it different from IBD?","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.037_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2025.06.037_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"R\u00fchlemann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2025.06.037_bib36","doi-asserted-by":"crossref","first-page":"18321","DOI":"10.1073\/pnas.1406199111","article-title":"Microbiota organization is a distinct feature of proximal colorectal cancers","volume":"111","author":"Dejea","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2025.06.037_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.12688\/wellcomeopenres.16901.1","article-title":"Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease","volume":"6","author":"Ilott","year":"2021","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.cgh.2025.06.037_bib38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00204-011-0648-7","article-title":"Carcinogenicity of deoxycholate, a secondary bile acid","volume":"85","author":"Bernstein","year":"2011","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cgh.2025.06.037_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2025.06.037_bib40","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S2210-7401(12)70017-7","article-title":"Primary sclerosing cholangitis and bile acids","volume":"36","author":"Chazouilleres","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.037_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2050640617708953","article-title":"The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"6","author":"Torres","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2025.06.037_bib42","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2025.06.037_bib43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cgh.2016.11.036","article-title":"Risk of rectal cancer after colectomy for patients with ulcerative colitis: a national cohort study","volume":"15","author":"Abdalla","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.06.037_bib44","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s12072-021-10214-6","article-title":"Increased risk of cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Lundberg B\u00e5ve","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2025.06.037_bib45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525006214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525006214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:43:08Z","timestamp":1779219788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525006214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1542356525006214"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2025.06.037","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2025.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}